|
The global biofilms treatment market size is expected to reach USD 4.08 Billion in 2032 and register a steady revenue CAGR of 7.9% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of burn injuries is a major factor driving market revenue growth . 180,000 fatalities are attributed to burns each year, with majority occurring in low- and middle-income countries. Non-fatal burn injuries is one of the main reasons for morbidity. Burns typically occur at home or at work, which are preventable. Biofilms in burns cause serious problems since they cause 60% of burn mortality and quickly develop antibiotic resistance in bacterial colonies. Acinetobacter baumanii, methicillin-resistant staphylococcus aureus, and pseudomonas aeruginosa are important pathogens. This objective is to identify novel and established therapies to reduce biofilms on patient burns, hospital surfaces, and equipment. The report also offers estimations and predictions about the market segment and sub-segments exhibiting promising growth in the forecast timeline. The report also provides deeper insights into the technological advancements, industrial landscape, and emerging product and technological developments in the Biofilms Treatment market. It offers fruitful insights into the business sphere to help businesses capitalize on the lucrative growth opportunities. Competitive Terrain: The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Biofilms Treatment market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic. The leading market contenders listed in the report are: Smith+Nephew, Mimedx Group, Convatec Inc., Integra LifeSciences, Paul Hartmann AG, Molnlycke Health Care AB, Coloplast Group, B. Braun SE, Organogenesis Inc., and Bioventus LLC Emergen Research has segmented the global Biofilms Treatment market on the basis of type, application, end-use, and region: Segments Covered in this report are: - Product Outlook (Revenue, USD Billion; 2019–2032)
- Debridement Equipment
- Gauzes & Dressing
- Grafts & Matrices
- Wipes, Pads, and Lavage Solutions
- Gels, Ointments, & Sprays
- Wound Type Outlook (Revenue, USD Billion; 2019–2032)
- Surgical & Traumatic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Burns & Other Open Wounds
- End-Use Outlook (Revenue, USD Billion; 2019–2032)
- Hospitals, ASCs, & Wound Care Centers
- Home Care Settings
- Other End-Use
The various regions analyzed in the report include: - North America (US, Canada)
- Europe (UK, Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of MEA)
Key Objectives of the Report: - Analysis and estimation of the Biofilms Treatment Market size and share for the projected period of 2022-2030
- Extensive analysis of the key players of the market by SWOT analysis and Porter's Five Forces analysis to impart a clear understanding of the competitive landscape
- Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Biofilms Treatment Market
- Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
- Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
|
发表于 2024-3-22 14:56:45